Prot #AC-065A308: The efficacy and safety of initial triple versus initial dual oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: A multi-center, double-blind, placebo-controlled, Phase 3b study

  • Cajigas, Hector R (PD/PI)

Project: Research project

Project Details

Effective start/end date6/28/166/28/19


  • Chiltern International, Inc. (Prot# AC-065A308 // Prot# AC-065A308)
  • Actelion Pharmaceuticals Ltd. (Prot# AC-065A308 // Prot# AC-065A308)